N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomasFeng Yuan, Chiyuan Ma, Xiangming Cai et al.|Exploration of Targeted Anti-tumor Therapy|2022Cited by 2